Glenmark Pharma bets big on novel biologics category - Business Standard
February 10, 2007| Glenmark Pharma bets big on novel biologics category Business Standard, India - Glenmarkâs obesity drug GRC 10801 is also scheduled to enter Phase I trials within one or two months, and the PDE4 inhibitor for rheumatoid arthritis and ... |